Product code QAU— General, Plastic Surgery
PuraStat
- Classification name
- Hemostatic Device For Endoscopic Gastrointestinal Use
- Device class
- Class 2
- Regulation
- 21 CFR 878.4456
- Advisory panel
- General, Plastic Surgery
- Total cleared
- 12
- First cleared
- Most recent
FDA classification definition
“Hemostatic device for intraluminal gastrointestinal use. A hemostatic device for intraluminal gastrointestinal use is a prescription device that is endoscopically applied to the upper and/or lower gastrointestinal tract and is intended to produce hemostasis via absorption of fluid or by other physical means.”
Market context for product code QAU
FDA has cleared devices under product code QAU between 2018 and 2026, filed by 6 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.
Clearances per year
- 2026
- 2024
- 2023
- 2022
- 2021
- 2020
- 2018
Top applicants under product code QAU
Adverse events under product code QAU
product code QAU- Death
- 6
- Injury
- 135
- Malfunction
- 621
- Total
- 762
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Recent clearances under product code QAU
- K261503 — PuraStat GI
- K253302 — Hemospray Endoscopic Hemostat (HEMO-[X])
- K253924 — PuraStat
- K240994 — Nexpowder
- K242250 — PuraStat
- K234131 — Resolv Endoscopic Hemostat System
- K222481 — PuraStat
- K202929 — Nexpowder
- K210098 — PuraStat-GI
- K190677 — EndoClot
- K200972 — Hemospray Endoscopic Hemostat
- DEN170015 — Hemospray Endoscopic Hemostat
Data sourced from openFDA. This site is unofficial and independent of the FDA.